AOP Orphan Pharmaceuticals Aktiengesellschaft
Contact:
AOP
Phone: +43 503 72 44 24
E-Mail: nina.roth@aoporphan.com
Contact:
AOP
Phone: +43 503 72 44 24
E-Mail: nina.roth@aoporphan.com
KEYWORDS:
- Polycythaemia Vera
- BESREMi
- Ropeginterferon
- AOP Orphan
- PharmaEssentia
Download Photos
AOP Orphan Pharmaceuticals Aktiengesellschaft (21 releases)
1 2 3 Next »
Today the Higher Regional Court of Frankfurt declared enforceable the October 2020 award pertaining to the arbitration between AOP Orphan and PharmaEssentia Corp. The agreement between AOP Orphan and PharmaEssentia Corp.remains in full force and effect, and AOP Orphan is entitled to damages from PharmaEssentia of approx. EUR 142 million. [more]
|
AOP Orphan announces European approvable opinion of its ultra-short acting beta blocker Rapibloc®
2016-07-11, pts20160711014 Health/Medicine, Products/Innovations |
1 2 3 Next »
